Practical and Sustainable Synthesis of Optically Pure Levocabastine, a H1 Receptor Antagonist
A practical and sustainable method for the synthesis of levocabastine hydrochloride (1), a H1 receptor antagonist for the treatment of allergic conjunctivitis, that can be applied to the industrial production of the compound has been developed. Substantial improvements over the previously reported p...
Main Authors: | Sung Kwon Kang, Dong Hyuk Nam, Jaeseung Ahn, Jaemin Lee, Jaehoon Sim, Jeeyeon Lee, Young-Ger Suh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/11/1971 |
Similar Items
-
The Early Efficacy of Topical Levocabastine in Patients with Allergic Conjunctivitis
by: Hiroshi Fujishima, et al.
Published: (2006-01-01) -
Development and validation of stability-indicating RP-HPLC method for the determination of Levocabastine HCl in bulk drug and in ophthalmic suspensions
by: Hashem AlAani, et al.
Published: (2017-05-01) -
Modern opportunities of therapeutic treatment of allergic conjunctivitis. A review
by: D. Yu. Maychuk
Published: (2014-07-01) -
Comparative Study to Assess Clinical Efficacy of Leukotriene Receptor Antagonist and Antihistamines in the Treatment of Allergic Rhinitis
by: Gurpreet Kaur, et al.
Published: (2017-08-01) -
Comparative Study to Assess Clinical Efficacy of Leukotriene Receptor Antagonist and Antihistamines in the Treatment of Allergic Rhinitis
by: Gurpreet Kaur, et al.
Published: (2017-08-01)